Advances in the Management of Patients with Diabetic Kidney Disease in the Setting of Type 2 Diabetes
Advances in the Management of Patients with Diabetic Kidney Disease in the Setting of Type 2 Diabetes is organized by AcademicCME.
Program Dates: February 27th, 2023 - February 26th, 2024
Program Overview:
New, actionable data on the use of sodium-glucose co-transporter-2 (SGLT2) inhibitors was released at several major meetings in 2022, culminating in November at ASN/Kidney Week that herald signal advances in the management of DKD/T2D. These new data and an expert contextualization of their role in contemporary practice is the basis of this webcast.
Agenda:
• Review and analyze the latest therapeutic advances for the management of DKD in the setting of T2D as presented and explored at major congresses in 2022, with an emphasis on SGLT-2 inhibitor therapy
• Apply new data and therapeutic advances into evidence-driven treatment strategies to improve the care of patients T2D and DKD
Learning Objectives:
• Review and analyze the latest therapeutic advances for the management of DKD in the setting of T2D as presented and explored at major congresses in 2022, with an emphasis on SGLT-2 inhibitor therapy
• Apply new data and therapeutic advances into evidence-driven treatment strategies to improve the care of patients T2D and DKD
Additional details will be posted as soon as information is available.